Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
21
datasets available to search
ShareScore release 0.9.0
Dataset results
21 results for “high sensitive cardiac troponin”
Use of High Sensitivity Cardiac Troponin in Ruling Out Emergency Patients with Acute Myocardial Injury and Infarction
ClinicalTrials.gov study NCT04280926. IPD Sharing: NO. Countries: 1. Publications: 1.
Comparison Between High-sensitivity Cardiac Troponin T and Standard Tnl Assays in Early Cardiac Ischemia Detection
ClinicalTrials.gov study NCT01374607. IPD Sharing: NO. Countries: 1. Publications: 2.
Rapid Use of High-sensitive Cardiac Troponin I for ruling-in and Ruling-out of Acute Myocardial Infarction
ClinicalTrials.gov study NCT03634384. IPD Sharing: NO. Countries: 1. Publications: 11.
Trial of Cardiac CT in Acute Chest Patients With Intermediate Level Initial High-sensitivity Cardiac Troponin
ClinicalTrials.gov study NCT03583320. IPD Sharing: YES. Countries: 1. Publications: 26.
Acute MI Staging Diagnosis by High-sensitivity Cardiac Troponin-I
ClinicalTrials.gov study NCT07163988. IPD Sharing: NO. Countries: 2. Publications: 3.
Diagnostic Utility of Copeptin in Addition to High-sensitivity Cardiac Troponin for the Early Diagnosis of NSTE-ACS
ClinicalTrials.gov study NCT01962506. IPD Sharing: Not stated. Countries: 1. Publications: 1.
High-sensitivity Troponin T in Acute Myocardial Infarction After Cardiac Valvular Surgery
ClinicalTrials.gov study NCT02518282. IPD Sharing: Not stated. Countries: 1. Publications: 6.
High-sensitivity Troponin in Cardiac Surgery
ClinicalTrials.gov study NCT01913873. IPD Sharing: Not stated. Countries: 1. Publications: 6.
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
ClinicalTrials.gov study NCT02984436. IPD Sharing: NO. Countries: 1. Publications: 7.
Data from: Association of high-sensitivity cardiac troponin T with mortality and cardiovascular events in a community-based prospective study in Beijing
Objective: The prognostic value of cardiac troponins in apparently healthy populations is not well established. The aim of this study was to investigate the prognostic properties of high-sensitivity cardiac troponin T (hs-cTnT) for long-term adverse outcomes. Setting: A community-dwelling prospective survey of residents from two communities in Beijing. Participants: From September 2007 to January 2009, 1680 participants were initially enrolled. Of these, 1499 (870 females, mean age: 61.4 years) participants completed the survey and were followed up for a median of 4.8 years (interquartile range: 4.5–5.2). Outcome measures: The primary outcome was the occurrence of all-cause mortality and major cardiovascular events. Results: Overall, 820 individuals (54.7%) had detectable hs-cTnT levels. During the follow-up, 52 participants (3.5%) died, 154 (10.3%) had major cardiovascular events, and 99 (6.6%) experienced new-onset coronary events. Compared with those with undetectable hs-cTnT levels, participants with hs-cTnT levels in the highest category(≥14 ng/L) had a significantly increased risk for all-cause mortality (adjusted hazard ratio [aHR] : 2.07, 95% confidence interval [CI]: 1.05–3.01), major cardiovascular events (aHR: 3.27, 95% CI: 1.88–5.70), and coronary events (aHR: 4.50, 95% CI: 2.26–9.02) in covariate-adjusted analyses. No differences in stroke incidence were found (aHR: 1.27; 95% CI: 0.69–2.62). Also, significant associations were presented when hs-cTnT levels were modelled as a continuous variable and when analysing changes in hs-cTnT levels over time with adverse outcomes. The addition of troponin T levels to clinical variables led to significant increases in risk prediction with a marked improvement in the c-statistic (P=0.003 or lower). Conclusions: In this cohort of individuals from a community-based population, cardiac troponin T levels measured with a highly sensitive assay were associated with increases in the subsequent risk for all-cause mortality and major cardiovascular events. These results might support screening for at-risk individuals.
High-Sensitivity Cardiac Troponin On Presentation to Rule Out Myocardial Infarction
ClinicalTrials.gov study NCT03005158. IPD Sharing: UNDECIDED. Countries: 0. Publications: 5.
Study of the Effect of Serelaxin on High-sensitivity Cardiac Troponin I (Hs-cTnI) Release in Patients With Chronic Heart Failure
ClinicalTrials.gov study NCT02625922. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Early Detection of Cardiomyopathy by Speckle Echo, High Sensitive Troponin and Cardiac Ryanodine Receptors
ClinicalTrials.gov study NCT03381014. IPD Sharing: Not stated. Countries: 0. Publications: 2.
High Sensitivity Cardiac Troponin T in Patients With Atrial Fibrillation Admitted to an Emergency Department (ED)
ClinicalTrials.gov study NCT02542189. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Data from: Association of high-sensitivity cardiac troponin T with mortality and cardiovascular events in a community-based prospective study in Beijing
Open the record for dataset details and reuse information.
Study on the Predictive Value of High-sensitivity Cardiac Troponin I, N-terminal Pro-B-natriuretic Peptide, and Soluble Suppression of Tumorigenesis-2 for Mortality and the Development of Cardiovascul
ClinicalTrials.gov study NCT06902857. IPD Sharing: NO. Countries: 1. Publications: 0.
Reference Interval Validation of High-Sensitivity Cardiac Troponin T Assay in Thai Population
ClinicalTrials.gov study NCT03968016. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Highly Sensitive Serum Cardiac Troponin T and Cardiovascular Events in Patients With Systemic Lupus Erythematosus
ClinicalTrials.gov study NCT04580108. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Impact of Hospitalization on High-sensitivity Cardiac Troponin T Concentrations Depending on Disease Severity
ClinicalTrials.gov study NCT04963400. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial
ClinicalTrials.gov study NCT03214029. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.